ICON Public Limited Company
Every calculator, already run for ICLR
Open the full toolkit →You have the numbers on ICLR. Get the argument.
A written report on which of these readings actually decide the outcome for ICON Public Limited Company, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
18 analysts covering ICLRAnalyst Price Target Disagreement for ICON Public Limited Company
Wall Street's bull case implies +0% from the current price; the bear case implies -28%. Analysts are relatively aligned on ICLR's range.
Ownership & short interest
Insider Trading Activity for ICLR
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinic…
ICLR — frequently asked
Is ICLR a buy right now?
Wall Street's consensus rating on ICON Public Limited Company is Buy across 18 analysts, with a mean price target of $188.24 (-12% vs. the current $214.16). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is ICLR overvalued?
ICLR trades at 85.7x trailing earnings, against a DCF fair value of $157 per share. The current price implies 10% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
What is the analyst price target disagreement for ICON Public Limited Company?
Analysts covering ICON Public Limited Company (ICLR) range from a bear-case target of $155.00 to a bull-case high of $215.00, with a mean consensus target of $188.24 across 17 analysts. The spread of $60.00 (28% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare ICON Public Limited Company against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For ICON Public Limited Company
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full ICLR research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on ICON Public Limited Company, in minutes. 3 free reports included with every account — no credit card required.